NOV: NOVOBIOCIN
NOV is a Ligand Of Interest in 6B89 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 6B89_NOV_B_403 | 90% | 73% | 0.068 | 0.957 | 0.3 | 0.6 | - | 1 | 2 | 0 | 100% | 1 |
| 6B89_NOV_A_403 | 88% | 74% | 0.068 | 0.95 | 0.29 | 0.6 | - | 1 | 1 | 0 | 100% | 1 |
| 6MIT_NOV_E_302 | 6% | 22% | 0.242 | 0.691 | 1.68 | 1.48 | 7 | 10 | 3 | 0 | 100% | 1 |
| 7PTF_NOV_A_301 | 100% | 53% | 0.033 | 0.987 | 0.76 | 0.9 | 2 | 5 | 0 | 0 | 100% | 1 |
| 6Y8O_NOV_B_301 | 97% | 50% | 0.052 | 0.979 | 0.76 | 1.05 | - | 3 | 2 | 0 | 100% | 1 |
| 1AJ6_NOV_A_1 | 93% | 19% | 0.059 | 0.96 | 1.43 | 1.91 | 5 | 20 | 5 | 0 | 100% | 1 |
| 6Y8L_NOV_A_501 | 92% | 52% | 0.069 | 0.968 | 0.81 | 0.91 | 1 | 4 | 14 | 0 | 100% | 0.5 |
| 4URO_NOV_B_2000 | 84% | 51% | 0.079 | 0.945 | 0.85 | 0.92 | 2 | 3 | 2 | 0 | 100% | 1 |